Clinical Trials Logo

Filter by:
NCT ID: NCT05206968 Recruiting - Clinical trials for Juvenile Idiopathic Arthritis Hip

Scoring System of Structural Damage for the Hip in Juvenile Idiopathic Arthritis

hip index
Start date: January 10, 2022
Study type: Observational

Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease in children affecting mobility and physical function. The hip involvement represents a frequent complication in JIA patients. The assessment of hip damage becomes a mandatory step in disease monitoring. However, radiological scoring was not standardized. This study aimed to compare the two scoring systems previously proposed, examine their repeatability and their intra and inter agreement.

NCT ID: NCT05205655 Completed - Olfaction Clinical Trials

Detection Dogs as a Help in the Detection of COVID-19

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Canine olfactive detection has proven its efficacy in numerous situations (explosives, drugs, bank notes…) including for early diagnosis of human diseases: various cancers, alert of diabetic or epileptic people in immediate alarm of crisis.

NCT ID: NCT05204238 Recruiting - Heart Failure Clinical Trials

Follow Up of acuTe Heart failUre: a pRospective Echocardiographic and Clinical Study (FUTURE)

Start date: September 1, 2020
Study type: Observational

Acute heart failure (AHF) is defined as rapid onset or rapid worsening of typical signs and symptoms of heart failure (HF) according to the 2016 European Society of Cardiology Guidelines. AHF is the first cause of hospitalization in people over 65 in Western countries, accounting for more than 1 million hospitalizations per year in the USA. This disease has many repercussions not only in terms of mortality and morbidity, but also in terms of resources and infrastructures necessary for these patients' treatment, which constitutes a high economic burden for the national health care system. Even with growing knowledge and means, nowadays, the prognosis of AHF is still poor and there are no proven therapies that lead to long-term benefits in terms of reduced mortality. A better management of the acute phase of decompensation, including the definition of effective diagnostic-therapeutic workup and the use of innovative drugs, could improve the course of the disease, with positive effects on the patient (gain in survival and reduction of admissions), but also on the community (containment of the overall health costs). In recent years, numerous scores have been outlined in various AHF settings, considering only a small number of parameters. Several prognostic models have been developed suggesting how difficult it is to evaluate the AHF patients' prognosis. All this effort towards the development of so numerous prognostic models is justified by the fact that, despite the evolution of treatments, the risk of re-hospitalization and of both intrahospital mortality and after discharge remains high. Several studies have investigated potential prognostic factors that could help evaluating the risk of cardiovascular events, but now there is no accurate and complete prognostic score, particularly for AHF patients. Therefore, to date there are no accurate scores or determinants of short- and medium-term prognosis that allow to improve the management of these patients. This will be an observational, prospective, multicentric, international, non-commercial (non-profit) study. The primary endpoint will be to evaluate the best parameters, among clinical, laboratory and echocardiographic variables assessed within 24 hours from the hospital admission and before discharge, that are able to predict rehospitalization for HF and cardiovascular death at 3 and 6 months, in patients admitted to the cardiology department for acute exacerbation of chronic HF or de novo AHF.

NCT ID: NCT05189119 Completed - COPD Exacerbation Clinical Trials

Pressure Support (PS) Application Under NIV in the Early Diagnosis of Left Ventricular Failure in Chronic Obstructive Pulmonary Disease

Start date: May 2011
Study type: Observational

Left ventricular failure (LVF) is a common cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This association is frequently underestimated with regard to the difficulty of clinical diagnosis . The investigators expect that the application of pressure support under NIV could be useful in this issue.

NCT ID: NCT05152043 Completed - Hypertension Clinical Trials

Effects of Romadan Fasting on Variability in Blood Pressure in Healthy and Hypertensive Subjects

Start date: May 1, 2019
Study type: Observational

Included participants who have a stable HT who intend to practice RJ

NCT ID: NCT05149417 Recruiting - Post-traumatic Pain Clinical Trials

Effect of Telemedecine on Post -Trauma Pain Medication Adherence .

Start date: August 21, 2020
Phase: N/A
Study type: Interventional

The impact of telemonitoring on patients' adherence to post trauma pain treatment , their satisfaction and pain relief after discharge from the ED.

NCT ID: NCT05135338 Completed - Clinical trials for Chest X-ray ; Heart Failure

Chest X-ray in Diagnosis of Heart Failure

Start date: January 21, 2018
Study type: Observational

The objective of this study is to compare the performance of x-chest ray in the diagnosis of acute cardiac insuficiency through the interpretation of a senior and a non-senior.

NCT ID: NCT05126940 Completed - Dyspnea; Cardiac Clinical Trials

Bedside Lung Ultrasonography by Nurses in Acute Dyspnea.

Start date: January 1, 2018
Study type: Observational

This study assesses the potential of lung ultrasonography to diagnose heart failure.

NCT ID: NCT05094193 Recruiting - Clinical trials for Laparoscopic Cholecystectomy

Trocar-site Infiltration Versus TAP-block

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain during the 24 hours postoperative, which is routinely managed using opioids. The transversus abdominis plane (TAP) block has been used as part of a multimodal analgesia strategy. Besides, Wang et al found that TAP block is more effective than a conventional pain control, but not significatively different from another local incisional pain control that is port site infiltration.So, the aim of this study, is to compare the analgesic efficacy and safety of trocar-site infiltration with ropivacaine with ultrasound-guided TAP block following laparoscopic cholecystectomy when used as part of multimodal analgesia.

NCT ID: NCT05079880 Recruiting - Clinical trials for Laparoscopic Cholecystectomy

Effect of Caffeine on Time to Anesthetic Emergence After Laparoscopic Cholecystectomy : Randomized-controlled Trial

Start date: August 15, 2021
Phase: Phase 2
Study type: Interventional

A faster emergence from general anesthesia has a double medico-economic impact by reducing the risks of complications and optimizing the performance of surgical units. No drug has been retained for its ability to actively accelerate anesthetic emergence by antagonizing hypnotics. Thus, the aim of this study was to examine the effect of caffeine on the time to emerge from sevoflurane anesthesia for laparoscopic cholecystectomy.